Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, code, cloud, nicecloud)
 

'en:blastic phase'
(id=7204216 ; fe=en:blastic phase ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=7836 creation date=2017-06-26 touchdate=2026-01-07 18:13:28.000)
≈ 76 relations sortantes

  1. en:blastic phase -- r_associated #0: 29 / 1 -> en:hypoprolactinemia
    n1=en:blastic phase | n2=en:hypoprolactinemia | rel=r_associated | relid=0 | w=29
  2. en:blastic phase -- r_associated #0: 28 / 0.966 -> en:pancreatic enzymes decreased
    n1=en:blastic phase | n2=en:pancreatic enzymes decreased | rel=r_associated | relid=0 | w=28
  3. en:blastic phase -- r_associated #0: 22 / 0.759 -> en:hyperlipidemia
    n1=en:blastic phase | n2=en:hyperlipidemia | rel=r_associated | relid=0 | w=22
  4. en:blastic phase -- r_associated #0: 21 / 0.724 -> en:abnormal blood prolactin
    n1=en:blastic phase | n2=en:abnormal blood prolactin | rel=r_associated | relid=0 | w=21
  5. en:blastic phase -- r_associated #0: 20 / 0.69 -> azote non protéinique augmenté
    n1=en:blastic phase | n2=azote non protéinique augmenté | rel=r_associated | relid=0 | w=20
  6. en:blastic phase -- r_associated #0: 20 / 0.69 -> azote non protéique augmenté
    n1=en:blastic phase | n2=azote non protéique augmenté | rel=r_associated | relid=0 | w=20
  7. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:abnormal hematology test result
    n1=en:blastic phase | n2=en:abnormal hematology test result | rel=r_associated | relid=0 | w=20
  8. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:alpha fetoprotein increased
    n1=en:blastic phase | n2=en:alpha fetoprotein increased | rel=r_associated | relid=0 | w=20
  9. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:blood alkaline phosphatase increased
    n1=en:blastic phase | n2=en:blood alkaline phosphatase increased | rel=r_associated | relid=0 | w=20
  10. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:creatine phosphokinase increased
    n1=en:blastic phase | n2=en:creatine phosphokinase increased | rel=r_associated | relid=0 | w=20
  11. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:ctrp terminology
    n1=en:blastic phase | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=20
  12. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:elevated alkaline phosphatase
    n1=en:blastic phase | n2=en:elevated alkaline phosphatase | rel=r_associated | relid=0 | w=20
  13. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:fibrinogen decreased
    n1=en:blastic phase | n2=en:fibrinogen decreased | rel=r_associated | relid=0 | w=20
  14. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:fungaemia
    n1=en:blastic phase | n2=en:fungaemia | rel=r_associated | relid=0 | w=20
  15. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:fungal septicaemia
    n1=en:blastic phase | n2=en:fungal septicaemia | rel=r_associated | relid=0 | w=20
  16. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:fungemia
    n1=en:blastic phase | n2=en:fungemia | rel=r_associated | relid=0 | w=20
  17. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:gamma-glutamyltransferase increased
    n1=en:blastic phase | n2=en:gamma-glutamyltransferase increased | rel=r_associated | relid=0 | w=20
  18. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:haptoglobin decreased
    n1=en:blastic phase | n2=en:haptoglobin decreased | rel=r_associated | relid=0 | w=20
  19. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hypercalcaemia
    n1=en:blastic phase | n2=en:hypercalcaemia | rel=r_associated | relid=0 | w=20
  20. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hypercalcemia
    n1=en:blastic phase | n2=en:hypercalcemia | rel=r_associated | relid=0 | w=20
  21. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hypercarbia
    n1=en:blastic phase | n2=en:hypercarbia | rel=r_associated | relid=0 | w=20
  22. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hypercholesterolemia
    n1=en:blastic phase | n2=en:hypercholesterolemia | rel=r_associated | relid=0 | w=20
  23. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hyperglucagonemia
    n1=en:blastic phase | n2=en:hyperglucagonemia | rel=r_associated | relid=0 | w=20
  24. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hyperkalemia
    n1=en:blastic phase | n2=en:hyperkalemia | rel=r_associated | relid=0 | w=20
  25. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hyperlipasemia
    n1=en:blastic phase | n2=en:hyperlipasemia | rel=r_associated | relid=0 | w=20
  26. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hyperlipemia
    n1=en:blastic phase | n2=en:hyperlipemia | rel=r_associated | relid=0 | w=20
  27. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hyperlipidaemia
    n1=en:blastic phase | n2=en:hyperlipidaemia | rel=r_associated | relid=0 | w=20
  28. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hyperlipoproteinemia
    n1=en:blastic phase | n2=en:hyperlipoproteinemia | rel=r_associated | relid=0 | w=20
  29. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hyperphosphatemia
    n1=en:blastic phase | n2=en:hyperphosphatemia | rel=r_associated | relid=0 | w=20
  30. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hyperprolactinemia
    n1=en:blastic phase | n2=en:hyperprolactinemia | rel=r_associated | relid=0 | w=20
  31. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hypertriglyceridemia
    n1=en:blastic phase | n2=en:hypertriglyceridemia | rel=r_associated | relid=0 | w=20
  32. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hypoalbuminemia
    n1=en:blastic phase | n2=en:hypoalbuminemia | rel=r_associated | relid=0 | w=20
  33. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hypocalcemia
    n1=en:blastic phase | n2=en:hypocalcemia | rel=r_associated | relid=0 | w=20
  34. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hypochromia
    n1=en:blastic phase | n2=en:hypochromia | rel=r_associated | relid=0 | w=20
  35. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hyponatremia
    n1=en:blastic phase | n2=en:hyponatremia | rel=r_associated | relid=0 | w=20
  36. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:hypophosphatemia
    n1=en:blastic phase | n2=en:hypophosphatemia | rel=r_associated | relid=0 | w=20
  37. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:increased creatinine
    n1=en:blastic phase | n2=en:increased creatinine | rel=r_associated | relid=0 | w=20
  38. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:increased npn
    n1=en:blastic phase | n2=en:increased npn | rel=r_associated | relid=0 | w=20
  39. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:inr increased
    n1=en:blastic phase | n2=en:inr increased | rel=r_associated | relid=0 | w=20
  40. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:lactate dehydrogenase increased
    n1=en:blastic phase | n2=en:lactate dehydrogenase increased | rel=r_associated | relid=0 | w=20
  41. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:systemic mycosis
    n1=en:blastic phase | n2=en:systemic mycosis | rel=r_associated | relid=0 | w=20
  42. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:transaminitis
    n1=en:blastic phase | n2=en:transaminitis | rel=r_associated | relid=0 | w=20
  43. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:viral infection
    n1=en:blastic phase | n2=en:viral infection | rel=r_associated | relid=0 | w=20
  44. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:viremia
    n1=en:blastic phase | n2=en:viremia | rel=r_associated | relid=0 | w=20
  45. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:virose
    n1=en:blastic phase | n2=en:virose | rel=r_associated | relid=0 | w=20
  46. en:blastic phase -- r_associated #0: 20 / 0.69 -> en:virosis
    n1=en:blastic phase | n2=en:virosis | rel=r_associated | relid=0 | w=20
  47. en:blastic phase -- r_associated #0: 20 / 0.69 -> fongémie
    n1=en:blastic phase | n2=fongémie | rel=r_associated | relid=0 | w=20
  48. en:blastic phase -- r_associated #0: 20 / 0.69 -> fongémies
    n1=en:blastic phase | n2=fongémies | rel=r_associated | relid=0 | w=20
  49. en:blastic phase -- r_associated #0: 20 / 0.69 -> hypercalcémie
    n1=en:blastic phase | n2=hypercalcémie | rel=r_associated | relid=0 | w=20
  50. en:blastic phase -- r_associated #0: 20 / 0.69 -> hypercapnie
    n1=en:blastic phase | n2=hypercapnie | rel=r_associated | relid=0 | w=20
  51. en:blastic phase -- r_associated #0: 20 / 0.69 -> hypercarbie
    n1=en:blastic phase | n2=hypercarbie | rel=r_associated | relid=0 | w=20
  52. en:blastic phase -- r_associated #0: 20 / 0.69 -> hyperlipémie
    n1=en:blastic phase | n2=hyperlipémie | rel=r_associated | relid=0 | w=20
  53. en:blastic phase -- r_associated #0: 20 / 0.69 -> hyperlipidémie
    n1=en:blastic phase | n2=hyperlipidémie | rel=r_associated | relid=0 | w=20
  54. en:blastic phase -- r_associated #0: 20 / 0.69 -> hyperphosphatémie
    n1=en:blastic phase | n2=hyperphosphatémie | rel=r_associated | relid=0 | w=20
  55. en:blastic phase -- r_associated #0: 20 / 0.69 -> hypertriglycéridémie
    n1=en:blastic phase | n2=hypertriglycéridémie | rel=r_associated | relid=0 | w=20
  56. en:blastic phase -- r_associated #0: 20 / 0.69 -> hypo-albuminémie
    n1=en:blastic phase | n2=hypo-albuminémie | rel=r_associated | relid=0 | w=20
  57. en:blastic phase -- r_associated #0: 20 / 0.69 -> hypoalbuminémie
    n1=en:blastic phase | n2=hypoalbuminémie | rel=r_associated | relid=0 | w=20
  58. en:blastic phase -- r_associated #0: 20 / 0.69 -> hypocalcémie
    n1=en:blastic phase | n2=hypocalcémie | rel=r_associated | relid=0 | w=20
  59. en:blastic phase -- r_associated #0: 20 / 0.69 -> hypochromie
    n1=en:blastic phase | n2=hypochromie | rel=r_associated | relid=0 | w=20
  60. en:blastic phase -- r_associated #0: 20 / 0.69 -> infection due au rétrovirus
    n1=en:blastic phase | n2=infection due au rétrovirus | rel=r_associated | relid=0 | w=20
  61. en:blastic phase -- r_associated #0: 20 / 0.69 -> infection mycosique systémique
    n1=en:blastic phase | n2=infection mycosique systémique | rel=r_associated | relid=0 | w=20
  62. en:blastic phase -- r_associated #0: 20 / 0.69 -> infection virale
    n1=en:blastic phase | n2=infection virale | rel=r_associated | relid=0 | w=20
  63. en:blastic phase -- r_associated #0: 20 / 0.69 -> infections virales
    n1=en:blastic phase | n2=infections virales | rel=r_associated | relid=0 | w=20
  64. en:blastic phase -- r_associated #0: 20 / 0.69 -> maladie à cytomégalovirus
    n1=en:blastic phase | n2=maladie à cytomégalovirus | rel=r_associated | relid=0 | w=20
  65. en:blastic phase -- r_associated #0: 20 / 0.69 -> maladie due à un virus
    n1=en:blastic phase | n2=maladie due à un virus | rel=r_associated | relid=0 | w=20
  66. en:blastic phase -- r_associated #0: 20 / 0.69 -> maladie infectieuse virale
    n1=en:blastic phase | n2=maladie infectieuse virale | rel=r_associated | relid=0 | w=20
  67. en:blastic phase -- r_associated #0: 20 / 0.69 -> maladie virale
    n1=en:blastic phase | n2=maladie virale | rel=r_associated | relid=0 | w=20
  68. en:blastic phase -- r_associated #0: 20 / 0.69 -> maladies infectieuses virales
    n1=en:blastic phase | n2=maladies infectieuses virales | rel=r_associated | relid=0 | w=20
  69. en:blastic phase -- r_associated #0: 20 / 0.69 -> maladies virales
    n1=en:blastic phase | n2=maladies virales | rel=r_associated | relid=0 | w=20
  70. en:blastic phase -- r_associated #0: 20 / 0.69 -> mycose systémique
    n1=en:blastic phase | n2=mycose systémique | rel=r_associated | relid=0 | w=20
  71. en:blastic phase -- r_associated #0: 20 / 0.69 -> septicémie fongique
    n1=en:blastic phase | n2=septicémie fongique | rel=r_associated | relid=0 | w=20
  72. en:blastic phase -- r_associated #0: 20 / 0.69 -> septicémie mycosique
    n1=en:blastic phase | n2=septicémie mycosique | rel=r_associated | relid=0 | w=20
  73. en:blastic phase -- r_associated #0: 20 / 0.69 -> viémies
    n1=en:blastic phase | n2=viémies | rel=r_associated | relid=0 | w=20
  74. en:blastic phase -- r_associated #0: 20 / 0.69 -> virémie
    n1=en:blastic phase | n2=virémie | rel=r_associated | relid=0 | w=20
  75. en:blastic phase -- r_associated #0: 20 / 0.69 -> virose
    n1=en:blastic phase | n2=virose | rel=r_associated | relid=0 | w=20
  76. en:blastic phase -- r_associated #0: 20 / 0.69 -> viroses
    n1=en:blastic phase | n2=viroses | rel=r_associated | relid=0 | w=20
≈ 145 relations entrantes

  1. infection virale --- r_associated #0: 345 --> en:blastic phase
    n1=infection virale | n2=en:blastic phase | rel=r_associated | relid=0 | w=345
  2. en:viral infection --- r_associated #0: 341 --> en:blastic phase
    n1=en:viral infection | n2=en:blastic phase | rel=r_associated | relid=0 | w=341
  3. infection due au rétrovirus --- r_associated #0: 325 --> en:blastic phase
    n1=infection due au rétrovirus | n2=en:blastic phase | rel=r_associated | relid=0 | w=325
  4. en:viremia --- r_associated #0: 310 --> en:blastic phase
    n1=en:viremia | n2=en:blastic phase | rel=r_associated | relid=0 | w=310
  5. maladie due à un virus --- r_associated #0: 310 --> en:blastic phase
    n1=maladie due à un virus | n2=en:blastic phase | rel=r_associated | relid=0 | w=310
  6. maladie infectieuse virale --- r_associated #0: 310 --> en:blastic phase
    n1=maladie infectieuse virale | n2=en:blastic phase | rel=r_associated | relid=0 | w=310
  7. maladie à cytomégalovirus --- r_associated #0: 310 --> en:blastic phase
    n1=maladie à cytomégalovirus | n2=en:blastic phase | rel=r_associated | relid=0 | w=310
  8. maladie virale --- r_associated #0: 295 --> en:blastic phase
    n1=maladie virale | n2=en:blastic phase | rel=r_associated | relid=0 | w=295
  9. virose --- r_associated #0: 290 --> en:blastic phase
    n1=virose | n2=en:blastic phase | rel=r_associated | relid=0 | w=290
  10. en:virose --- r_associated #0: 275 --> en:blastic phase
    n1=en:virose | n2=en:blastic phase | rel=r_associated | relid=0 | w=275
  11. viroses --- r_associated #0: 150 --> en:blastic phase
    n1=viroses | n2=en:blastic phase | rel=r_associated | relid=0 | w=150
  12. virémie --- r_associated #0: 150 --> en:blastic phase
    n1=virémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=150
  13. maladies virales --- r_associated #0: 140 --> en:blastic phase
    n1=maladies virales | n2=en:blastic phase | rel=r_associated | relid=0 | w=140
  14. septicémie fongique --- r_associated #0: 140 --> en:blastic phase
    n1=septicémie fongique | n2=en:blastic phase | rel=r_associated | relid=0 | w=140
  15. septicémie mycosique --- r_associated #0: 140 --> en:blastic phase
    n1=septicémie mycosique | n2=en:blastic phase | rel=r_associated | relid=0 | w=140
  16. en:fungemia --- r_associated #0: 131 --> en:blastic phase
    n1=en:fungemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=131
  17. fongémies --- r_associated #0: 131 --> en:blastic phase
    n1=fongémies | n2=en:blastic phase | rel=r_associated | relid=0 | w=131
  18. hypertriglycéridémie --- r_associated #0: 131 --> en:blastic phase
    n1=hypertriglycéridémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=131
  19. en:hypertriglyceridemia --- r_associated #0: 130 --> en:blastic phase
    n1=en:hypertriglyceridemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=130
  20. en:systemic mycosis --- r_associated #0: 125 --> en:blastic phase
    n1=en:systemic mycosis | n2=en:blastic phase | rel=r_associated | relid=0 | w=125
  21. infection mycosique systémique --- r_associated #0: 125 --> en:blastic phase
    n1=infection mycosique systémique | n2=en:blastic phase | rel=r_associated | relid=0 | w=125
  22. mycose systémique --- r_associated #0: 125 --> en:blastic phase
    n1=mycose systémique | n2=en:blastic phase | rel=r_associated | relid=0 | w=125
  23. hypercapnie --- r_associated #0: 124 --> en:blastic phase
    n1=hypercapnie | n2=en:blastic phase | rel=r_associated | relid=0 | w=124
  24. en:hypercarbia --- r_associated #0: 122 --> en:blastic phase
    n1=en:hypercarbia | n2=en:blastic phase | rel=r_associated | relid=0 | w=122
  25. fongémie --- r_associated #0: 121 --> en:blastic phase
    n1=fongémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=121
  26. infections virales --- r_associated #0: 120 --> en:blastic phase
    n1=infections virales | n2=en:blastic phase | rel=r_associated | relid=0 | w=120
  27. hypercarbie --- r_associated #0: 110 --> en:blastic phase
    n1=hypercarbie | n2=en:blastic phase | rel=r_associated | relid=0 | w=110
  28. maladies infectieuses virales --- r_associated #0: 110 --> en:blastic phase
    n1=maladies infectieuses virales | n2=en:blastic phase | rel=r_associated | relid=0 | w=110
  29. viémies --- r_associated #0: 95 --> en:blastic phase
    n1=viémies | n2=en:blastic phase | rel=r_associated | relid=0 | w=95
  30. hyperlipidémie --- r_associated #0: 61 --> en:blastic phase
    n1=hyperlipidémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=61
  31. en:hyperlipidaemia --- r_associated #0: 60 --> en:blastic phase
    n1=en:hyperlipidaemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=60
  32. hyperlipémie --- r_associated #0: 56 --> en:blastic phase
    n1=hyperlipémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=56
  33. en:hyperlipidemia --- r_associated #0: 54 --> en:blastic phase
    n1=en:hyperlipidemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=54
  34. en:fungal septicaemia --- r_associated #0: 49 --> en:blastic phase
    n1=en:fungal septicaemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=49
  35. en:fungaemia --- r_associated #0: 40 --> en:blastic phase
    n1=en:fungaemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=40
  36. en:hyperkalemia --- r_associated #0: 40 --> en:blastic phase
    n1=en:hyperkalemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=40
  37. en:hyperlipemia --- r_associated #0: 40 --> en:blastic phase
    n1=en:hyperlipemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=40
  38. en:virosis --- r_associated #0: 40 --> en:blastic phase
    n1=en:virosis | n2=en:blastic phase | rel=r_associated | relid=0 | w=40
  39. hypercalcémie --- r_associated #0: 39 --> en:blastic phase
    n1=hypercalcémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=39
  40. en:hypercalcemia --- r_associated #0: 38 --> en:blastic phase
    n1=en:hypercalcemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=38
  41. hypo-albuminémie --- r_associated #0: 36 --> en:blastic phase
    n1=hypo-albuminémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=36
  42. hypoalbuminémie --- r_associated #0: 36 --> en:blastic phase
    n1=hypoalbuminémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=36
  43. en:hypoalbuminemia --- r_associated #0: 35 --> en:blastic phase
    n1=en:hypoalbuminemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=35
  44. en:hypercholesterolemia --- r_associated #0: 34 --> en:blastic phase
    n1=en:hypercholesterolemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=34
  45. en:hyponatremia --- r_associated #0: 34 --> en:blastic phase
    n1=en:hyponatremia | n2=en:blastic phase | rel=r_associated | relid=0 | w=34
  46. en:abnormal blood prolactin --- r_associated #0: 32 --> en:blastic phase
    n1=en:abnormal blood prolactin | n2=en:blastic phase | rel=r_associated | relid=0 | w=32
  47. en:alpha fetoprotein increased --- r_associated #0: 32 --> en:blastic phase
    n1=en:alpha fetoprotein increased | n2=en:blastic phase | rel=r_associated | relid=0 | w=32
  48. en:creatine phosphokinase increased --- r_associated #0: 32 --> en:blastic phase
    n1=en:creatine phosphokinase increased | n2=en:blastic phase | rel=r_associated | relid=0 | w=32
  49. en:hypochromia --- r_associated #0: 32 --> en:blastic phase
    n1=en:hypochromia | n2=en:blastic phase | rel=r_associated | relid=0 | w=32
  50. en:lactate dehydrogenase increased --- r_associated #0: 32 --> en:blastic phase
    n1=en:lactate dehydrogenase increased | n2=en:blastic phase | rel=r_associated | relid=0 | w=32
  51. azote non protéinique augmenté --- r_associated #0: 31 --> en:blastic phase
    n1=azote non protéinique augmenté | n2=en:blastic phase | rel=r_associated | relid=0 | w=31
  52. azote non protéique augmenté --- r_associated #0: 31 --> en:blastic phase
    n1=azote non protéique augmenté | n2=en:blastic phase | rel=r_associated | relid=0 | w=31
  53. en:abnormal hematology test result --- r_associated #0: 31 --> en:blastic phase
    n1=en:abnormal hematology test result | n2=en:blastic phase | rel=r_associated | relid=0 | w=31
  54. en:haptoglobin decreased --- r_associated #0: 31 --> en:blastic phase
    n1=en:haptoglobin decreased | n2=en:blastic phase | rel=r_associated | relid=0 | w=31
  55. en:hyperlipasemia --- r_associated #0: 31 --> en:blastic phase
    n1=en:hyperlipasemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=31
  56. en:increased npn --- r_associated #0: 31 --> en:blastic phase
    n1=en:increased npn | n2=en:blastic phase | rel=r_associated | relid=0 | w=31
  57. hyperphosphatémie --- r_associated #0: 31 --> en:blastic phase
    n1=hyperphosphatémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=31
  58. hypochromie --- r_associated #0: 31 --> en:blastic phase
    n1=hypochromie | n2=en:blastic phase | rel=r_associated | relid=0 | w=31
  59. en:hyperprolactinemia --- r_associated #0: 30 --> en:blastic phase
    n1=en:hyperprolactinemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=30
  60. en:transaminitis --- r_associated #0: 30 --> en:blastic phase
    n1=en:transaminitis | n2=en:blastic phase | rel=r_associated | relid=0 | w=30
  61. en:ctrp terminology --- r_associated #0: 29 --> en:blastic phase
    n1=en:ctrp terminology | n2=en:blastic phase | rel=r_associated | relid=0 | w=29
  62. en:elevated alkaline phosphatase --- r_associated #0: 29 --> en:blastic phase
    n1=en:elevated alkaline phosphatase | n2=en:blastic phase | rel=r_associated | relid=0 | w=29
  63. en:hyperlipoproteinemia --- r_associated #0: 29 --> en:blastic phase
    n1=en:hyperlipoproteinemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=29
  64. en:increased creatinine --- r_associated #0: 29 --> en:blastic phase
    n1=en:increased creatinine | n2=en:blastic phase | rel=r_associated | relid=0 | w=29
  65. en:gamma-glutamyltransferase increased --- r_associated #0: 28 --> en:blastic phase
    n1=en:gamma-glutamyltransferase increased | n2=en:blastic phase | rel=r_associated | relid=0 | w=28
  66. en:hyperphosphatemia --- r_associated #0: 28 --> en:blastic phase
    n1=en:hyperphosphatemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=28
  67. en:blood alkaline phosphatase increased --- r_associated #0: 27 --> en:blastic phase
    n1=en:blood alkaline phosphatase increased | n2=en:blastic phase | rel=r_associated | relid=0 | w=27
  68. en:fibrinogen decreased --- r_associated #0: 27 --> en:blastic phase
    n1=en:fibrinogen decreased | n2=en:blastic phase | rel=r_associated | relid=0 | w=27
  69. en:hypercalcaemia --- r_associated #0: 27 --> en:blastic phase
    n1=en:hypercalcaemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=27
  70. en:hypophosphatemia --- r_associated #0: 27 --> en:blastic phase
    n1=en:hypophosphatemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=27
  71. en:inr increased --- r_associated #0: 27 --> en:blastic phase
    n1=en:inr increased | n2=en:blastic phase | rel=r_associated | relid=0 | w=27
  72. en:pancreatic enzymes decreased --- r_associated #0: 27 --> en:blastic phase
    n1=en:pancreatic enzymes decreased | n2=en:blastic phase | rel=r_associated | relid=0 | w=27
  73. en:hyperglucagonemia --- r_associated #0: 26 --> en:blastic phase
    n1=en:hyperglucagonemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=26
  74. en:hypocalcemia --- r_associated #0: 26 --> en:blastic phase
    n1=en:hypocalcemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=26
  75. en:hypoprolactinemia --- r_associated #0: 26 --> en:blastic phase
    n1=en:hypoprolactinemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=26
  76. hypocalcémie --- r_associated #0: 26 --> en:blastic phase
    n1=hypocalcémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=26
  77. en:cytomegalovirus infection --- r_associated #0: 25 --> en:blastic phase
    n1=en:cytomegalovirus infection | n2=en:blastic phase | rel=r_associated | relid=0 | w=25
  78. hypercholestérolémie --- r_associated #0: 25 --> en:blastic phase
    n1=hypercholestérolémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=25
  79. hyponatrémie --- r_associated #0: 25 --> en:blastic phase
    n1=hyponatrémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=25
  80. en:hyperlipoidaemia --- r_associated #0: 24 --> en:blastic phase
    n1=en:hyperlipoidaemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=24
  81. en:hyperlipaemia --- r_associated #0: 23 --> en:blastic phase
    n1=en:hyperlipaemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=23
  82. en:hyperkaliaemia --- r_associated #0: 22 --> en:blastic phase
    n1=en:hyperkaliaemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=22
  83. hyperkaliémie --- r_associated #0: 21 --> en:blastic phase
    n1=hyperkaliémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=21
  84. hypophosphatémie --- r_associated #0: 21 --> en:blastic phase
    n1=hypophosphatémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=21
  85. vireux --- r_associated #0: 21 --> en:blastic phase
    n1=vireux | n2=en:blastic phase | rel=r_associated | relid=0 | w=21
  86. Fong (syndrome de) --- r_associated #0: 15 --> en:blastic phase
    n1=Fong (syndrome de) | n2=en:blastic phase | rel=r_associated | relid=0 | w=15
  87. Hypochromie --- r_associated #0: 15 --> en:blastic phase
    n1=Hypochromie | n2=en:blastic phase | rel=r_associated | relid=0 | w=15
  88. Infection virale --- r_associated #0: 15 --> en:blastic phase
    n1=Infection virale | n2=en:blastic phase | rel=r_associated | relid=0 | w=15
  89. en:hypocalcaemia --- r_associated #0: 15 --> en:blastic phase
    n1=en:hypocalcaemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=15
  90. hyperintense (signal IRM) --- r_associated #0: 15 --> en:blastic phase
    n1=hyperintense (signal IRM) | n2=en:blastic phase | rel=r_associated | relid=0 | w=15
  91. hyperkératose nævoïde (hamartomateuse) du mamelon --- r_associated #0: 15 --> en:blastic phase
    n1=hyperkératose nævoïde (hamartomateuse) du mamelon | n2=en:blastic phase | rel=r_associated | relid=0 | w=15
  92. hyperperméabilité capillaire (syndrome d') --- r_associated #0: 15 --> en:blastic phase
    n1=hyperperméabilité capillaire (syndrome d') | n2=en:blastic phase | rel=r_associated | relid=0 | w=15
  93. hyperthyroïdie (manifestations neuromusculaires dans l') --- r_associated #0: 15 --> en:blastic phase
    n1=hyperthyroïdie (manifestations neuromusculaires dans l') | n2=en:blastic phase | rel=r_associated | relid=0 | w=15
  94. hypo-intense (signal IRM) --- r_associated #0: 15 --> en:blastic phase
    n1=hypo-intense (signal IRM) | n2=en:blastic phase | rel=r_associated | relid=0 | w=15
  95. Hypercalcémie --- r_associated #0: 10 --> en:blastic phase
    n1=Hypercalcémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  96. Hypercapnie --- r_associated #0: 10 --> en:blastic phase
    n1=Hypercapnie | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  97. Hypercholestérolémie --- r_associated #0: 10 --> en:blastic phase
    n1=Hypercholestérolémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  98. Hyperkaliémie --- r_associated #0: 10 --> en:blastic phase
    n1=Hyperkaliémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  99. Hyperlipidémie --- r_associated #0: 10 --> en:blastic phase
    n1=Hyperlipidémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  100. Hyperlipémie --- r_associated #0: 10 --> en:blastic phase
    n1=Hyperlipémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  101. Hypocalcémie --- r_associated #0: 10 --> en:blastic phase
    n1=Hypocalcémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  102. Hyponatrémie --- r_associated #0: 10 --> en:blastic phase
    n1=Hyponatrémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  103. Infections virales --- r_associated #0: 10 --> en:blastic phase
    n1=Infections virales | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  104. Maladie virale --- r_associated #0: 10 --> en:blastic phase
    n1=Maladie virale | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  105. Maladies virales --- r_associated #0: 10 --> en:blastic phase
    n1=Maladies virales | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  106. Virose --- r_associated #0: 10 --> en:blastic phase
    n1=Virose | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  107. en:hypercholesterolaemia --- r_associated #0: 10 --> en:blastic phase
    n1=en:hypercholesterolaemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  108. en:hyperintense --- r_associated #0: 10 --> en:blastic phase
    n1=en:hyperintense | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  109. en:hyperkeratosis of nipple and areola --- r_associated #0: 10 --> en:blastic phase
    n1=en:hyperkeratosis of nipple and areola | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  110. en:hypointense --- r_associated #0: 10 --> en:blastic phase
    n1=en:hypointense | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  111. en:hypophosphataemia --- r_associated #0: 10 --> en:blastic phase
    n1=en:hypophosphataemia | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  112. en:low blood phosphate --- r_associated #0: 10 --> en:blastic phase
    n1=en:low blood phosphate | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  113. en:nauseating --- r_associated #0: 10 --> en:blastic phase
    n1=en:nauseating | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  114. en:noxious --- r_associated #0: 10 --> en:blastic phase
    n1=en:noxious | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  115. en:sickening --- r_associated #0: 10 --> en:blastic phase
    n1=en:sickening | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  116. en:virous --- r_associated #0: 10 --> en:blastic phase
    n1=en:virous | n2=en:blastic phase | rel=r_associated | relid=0 | w=10
  117. Mycose systémique --- r_associated #0: 5 --> en:blastic phase
    n1=Mycose systémique | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  118. Virchow et Welcker (angle sphénoïdal de) --- r_associated #0: 5 --> en:blastic phase
    n1=Virchow et Welcker (angle sphénoïdal de) | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  119. hyperkeratosis follicularis et parafollicularis in cutem penetrans de Kyrle --- r_associated #0: 5 --> en:blastic phase
    n1=hyperkeratosis follicularis et parafollicularis in cutem penetrans de Kyrle | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  120. hyperkeratosis lenticularis perstans de Flegel --- r_associated #0: 5 --> en:blastic phase
    n1=hyperkeratosis lenticularis perstans de Flegel | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  121. hyperkinésie --- r_associated #0: 5 --> en:blastic phase
    n1=hyperkinésie | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  122. hyperkinésie volitionnelle --- r_associated #0: 5 --> en:blastic phase
    n1=hyperkinésie volitionnelle | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  123. hyperlacrymie --- r_associated #0: 5 --> en:blastic phase
    n1=hyperlacrymie | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  124. hyperlactacidémie --- r_associated #0: 5 --> en:blastic phase
    n1=hyperlactacidémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  125. hyperlaxité articulaire familiale --- r_associated #0: 5 --> en:blastic phase
    n1=hyperlaxité articulaire familiale | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  126. hyperlaxité ligamentaire --- r_associated #0: 5 --> en:blastic phase
    n1=hyperlaxité ligamentaire | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  127. hyperleucocytose --- r_associated #0: 5 --> en:blastic phase
    n1=hyperleucocytose | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  128. hyperphorie --- r_associated #0: 5 --> en:blastic phase
    n1=hyperphorie | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  129. hyperphorie alternante --- r_associated #0: 5 --> en:blastic phase
    n1=hyperphorie alternante | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  130. hyperphosphatasie --- r_associated #0: 5 --> en:blastic phase
    n1=hyperphosphatasie | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  131. hyperphosphatasémie --- r_associated #0: 5 --> en:blastic phase
    n1=hyperphosphatasémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  132. hyperphosphatasémie chronique congénitale idiopathique --- r_associated #0: 5 --> en:blastic phase
    n1=hyperphosphatasémie chronique congénitale idiopathique | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  133. hyperphénylalaninémie --- r_associated #0: 5 --> en:blastic phase
    n1=hyperphénylalaninémie | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  134. hypertrichose congénitale des cils --- r_associated #0: 5 --> en:blastic phase
    n1=hypertrichose congénitale des cils | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  135. hypertrichose lanugineuse acquise --- r_associated #0: 5 --> en:blastic phase
    n1=hypertrichose lanugineuse acquise | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  136. hypertrichose lanugineuse congénitale --- r_associated #0: 5 --> en:blastic phase
    n1=hypertrichose lanugineuse congénitale | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  137. hypertrichose nævoïde --- r_associated #0: 5 --> en:blastic phase
    n1=hypertrichose nævoïde | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  138. hypertrichose-atrophie cutanée-ectropion et macrostomie --- r_associated #0: 5 --> en:blastic phase
    n1=hypertrichose-atrophie cutanée-ectropion et macrostomie | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  139. hypertrichosis universalis congenita --- r_associated #0: 5 --> en:blastic phase
    n1=hypertrichosis universalis congenita | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  140. hypoaction d'un muscle oculomoteur --- r_associated #0: 5 --> en:blastic phase
    n1=hypoaction d'un muscle oculomoteur | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  141. hypoactivité vésicale --- r_associated #0: 5 --> en:blastic phase
    n1=hypoactivité vésicale | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  142. hypoadrénocorticisme avec hypoparathyroïdie et moniliase superficielle --- r_associated #0: 5 --> en:blastic phase
    n1=hypoadrénocorticisme avec hypoparathyroïdie et moniliase superficielle | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  143. prolactine sanguine anormale --- r_associated #0: 5 --> en:blastic phase
    n1=prolactine sanguine anormale | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  144. syndrome d'hyperperméabilité capillaire --- r_associated #0: 5 --> en:blastic phase
    n1=syndrome d'hyperperméabilité capillaire | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
  145. syndrome de Fong --- r_associated #0: 5 --> en:blastic phase
    n1=syndrome de Fong | n2=en:blastic phase | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr